Pharmaceuticals, Biotechnology and Life Sciences
DENVER–(BUSINESS WIRE)–#clinicaltrials–This summer, ClinOne and Boston Children’s Hospital (BCH) launched ClinOne’s eConsent with Video eConsent technology within Boston Children’s Pulmonary…
LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive…
AvantGen’s NK cell engager technology now available for partnering on a target-exclusive basis SAN DIEGO–(BUSINESS WIRE)–AvantGen, Inc., a biotechnology company…
BOSTON & LOUISVILLE, Ky.–(BUSINESS WIRE)–Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential…
KASSEL, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology…
TORONTO & SEOUL, South Korea–(BUSINESS WIRE)–#artificialintelligence–Renowned South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo…
VANCOUVER, British Columbia–(BUSINESS WIRE)–#antibodies–AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that…
Scynexis biotechnology company on Thursday announced positive top-line results for its Phase 3 VANISH-303 study investigating the safety and efficacy of oral ibrexafungerp as a treatment for women with vulvovaginal candidiasis (VVC).
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global vaccines market and the market is poised to grow by USD 13.81 billion…
– Prominent PWS clinical expert along with company management will discuss disease epidemiology, current treatment landscape and livoletide as a…